Japan investigates cancer "articles"

Share this article:

Japan's Health, Labor and Welfare Ministry is investigating a series of advertorials that were dressed up as articles but were in fact cancer-drug marketing efforts. Pharmalot reports that five unnamed drugmakers paid $18,500-$56,300 for articles in an unnamed publication so their cancer drugs would be slipped into articles. The setup is similar to television and movie product placement: the magazine wrote the article, entered quotes and plugged in drug names depending on payment.

Pharmalot says the publisher says everything done was legally.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.